Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study
Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923...
Saved in:
Published in | American journal of nephrology Vol. 53; no. 1; pp. 69 - 77 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
01.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107–237; Q2, 238–279; Q3, 280–326; Q4, 327–380; Q5, 381–755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Results: Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42–21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77–15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Conclusions: Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese. |
---|---|
AbstractList | Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. Methods: A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107–237; Q2, 238–279; Q3, 280–326; Q4, 327–380; Q5, 381–755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Results: Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42–21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77–15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Conclusions: Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese. Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the association between SUA levels and pathological findings of nephrosclerosis in population-based autopsy samples. A total of 923 deceased individuals in a Japanese community underwent autopsy examinations between 1974 and 1994. Of these, 547 individuals with available kidney tissues and health examination data within a median of 3 years before death were eligible for the present study. SUA levels were categorized into quintiles (Q1, 107-237; Q2, 238-279; Q3, 280-326; Q4, 327-380; Q5, 381-755 μmol/L). Advanced degrees of glomerular sclerosis, kidney arteriolar hyalinosis, and kidney arteriosclerosis were defined as the 90th percentile or more of a glomerular sclerosis index and an arteriolar hyalinosis index, and the 10th percentile or less of a wall-lumen ratio, respectively. A logistic regression model was used to evaluate odds ratios (ORs) and their 95% confidence intervals (CIs) of SUA levels on each kidney lesion. Higher SUA levels were significantly associated with higher values of the age- and sex-adjusted glomerular sclerosis index and lower values of the wall-lumen ratio (both p for trend <0.01). Individuals in the Q5 group had a significantly greater likelihood of advanced glomerular sclerosis (OR 7.19, 95% CI 2.42-21.38) and advanced kidney arteriosclerosis (OR 5.28, 95% CI 1.77-15.80) than individuals in the Q1 group after adjusting for potential covariates. There was no evidence of significant associations of SUA levels with either the arteriolar hyalinosis index or the presence of advanced arteriolar hyalinosis. Elevated SUA levels were significantly associated with advanced glomerular sclerosis and advanced kidney arteriosclerosis, but not with advanced arteriolar hyalinosis in community-based autopsy samples of Japanese. |
Author | Oishi, Emi Kitazono, Takanari Nakano, Toshiaki Oda, Yoshinao Furuta, Yoshihiko Sakata, Satoko Maki, Kenji Hata, Jun Ninomiya, Toshiharu |
Author_xml | – sequence: 1 givenname: Kenji surname: Maki fullname: Maki, Kenji – sequence: 2 givenname: Jun orcidid: 0000-0003-2698-344X surname: Hata fullname: Hata, Jun – sequence: 3 givenname: Satoko orcidid: 0000-0002-6750-5762 surname: Sakata fullname: Sakata, Satoko – sequence: 4 givenname: Emi orcidid: 0000-0002-3740-4119 surname: Oishi fullname: Oishi, Emi – sequence: 5 givenname: Yoshihiko orcidid: 0000-0003-2373-9636 surname: Furuta fullname: Furuta, Yoshihiko – sequence: 6 givenname: Toshiaki orcidid: 0000-0001-9235-5615 surname: Nakano fullname: Nakano, Toshiaki – sequence: 7 givenname: Yoshinao surname: Oda fullname: Oda, Yoshinao – sequence: 8 givenname: Takanari surname: Kitazono fullname: Kitazono, Takanari – sequence: 9 givenname: Toshiharu surname: Ninomiya fullname: Ninomiya, Toshiharu email: *Toshiharu Ninomiya, t.ninomiya.a47@m.kyushu-u.ac.jp |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35104828$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0MtLw0AQBvBFKvahB-8iC56js688vKVFrVKq0PZctpmNXc2LbCLkvzcQ9eRlPhh-fDAzJaOiLAwhlwxuGVPRHQAoziT3T8ikD-ZFfgAjMgGuwAshUmMyde4DgPEQgjMyFoqBDHk4IYeNqduc7mqb0DixSFfmy2SO6gLp2lTHunRJZvppHbUF1fStrNpMN7YsvLl2BmncNmXlOrppWuzu6fZo6NI63elcD7tzcprqzJmLn5yR3ePDdrH0Vq9Pz4t45SUqDBvPxzSSqUIZ9AEBUwxRcR0ILlEiCgAZsQgFk8wPhNQ-GhloqXhqooSFKGbkeuit2kNucF_VNtd1t_89tgc3A_jU9bup_0D8sh7et68w7dXVv2og4htXS2tt |
CitedBy_id | crossref_primary_10_1007_s40620_023_01605_z crossref_primary_10_5551_jat_64236 |
ContentType | Journal Article |
Copyright | 2022 The Author(s). Published by S. Karger AG, Basel 2022 The Author(s). Published by S. Karger AG, Basel. |
Copyright_xml | – notice: 2022 The Author(s). Published by S. Karger AG, Basel – notice: 2022 The Author(s). Published by S. Karger AG, Basel. |
DBID | M-- CGR CUY CVF ECM EIF NPM |
DOI | 10.1159/000521426 |
DatabaseName | Karger (Open access) Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: M-- name: Karger (Open access) url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1421-9670 |
EndPage | 77 |
ExternalDocumentID | 35104828 521426 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 23M 30W 327 34G 36B 39C 3O- 3O. 3V. 4.4 53G 5GY 5RE 6J9 7RV 7X7 88E 88I 8AF 8AO 8FI 8FJ 8UI AAWTL AAYIC ABJNI ABPAZ ABUWG ACGFO ACGFS ACGOD ACPRK ACPSR ADAGL ADBBV ADFRT AENEX AEYAO AFFNX AFJJK AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS APPQY AZPMC AZQEC BENPR BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DWQXO E0A EBS EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ HCIFZ HMCUK HZ~ IAO IHR IHW IY7 KUZGX M-- M1P M2P N9A NAPCQ O1H O9- OVD P2P PQQKQ PROAC PSQYO RIG RKO RXVBD S0X SV3 TEORI UJ6 UKHRP WOW X7M ZGI ZXP CGR CUY CVF ECM EIF ITC NPM |
ID | FETCH-LOGICAL-c588t-6df94f5d4794f07151dd52a7324d4dd3004919d31416734a6de47a452fe9c18d3 |
IEDL.DBID | M-- |
ISSN | 0250-8095 |
IngestDate | Sat Sep 28 08:24:38 EDT 2024 Thu Aug 29 12:04:38 EDT 2024 Thu Sep 05 17:59:11 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Population-based study Uric acid Nephrosclerosis Autopsy |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. 2022 The Author(s). Published by S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c588t-6df94f5d4794f07151dd52a7324d4dd3004919d31416734a6de47a452fe9c18d3 |
ORCID | 0000-0003-2373-9636 0000-0002-6750-5762 0000-0003-2698-344X 0000-0002-3740-4119 0000-0001-9235-5615 |
OpenAccessLink | https://karger.com/doi/10.1159/000521426 |
PMID | 35104828 |
PageCount | 9 |
ParticipantIDs | karger_primary_521426 pubmed_primary_35104828 |
PublicationCentury | 2000 |
PublicationDate | 2022-02-01 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland |
PublicationTitle | American journal of nephrology |
PublicationTitleAlternate | Am J Nephrol |
PublicationYear | 2022 |
References | Uedono H, Tsuda A, Ishimura E, Nakatani S, Kurajoh M, Mori K, . U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects. Am J Physiol Renal Physiol. 2017;312(6):F992–7. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, . Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama Study. Am J Kidney Dis. 2010;55(1):21–30. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26(2):137–43. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407–13. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008;19(6):1204–11. Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Haruyama N, Okabe Y, . Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease. Atherosclerosis. 2017;266:121–7. Sugihara S, Hisatome I, Kuwabara M, Niwa K, Maharani N, Kato M, . Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J. 2015;79(5):1125–32. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, . Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama Study. Kidney Int. 2003 Apr;63(4):1508–15. Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH. Effect of uric acid on the development of chronic kidney disease: the Korean multi-rural communities cohort study. J Prev Med Public Health. 2018;51(5):248–56. Tracy RE, MacLean CJ, Reed DM, Hayashi T, Gandia M, Strong JP. Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program. Mod Pathol. 1988 Nov;1(6):420–7. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004;555(3):589–606. Inaishi J, Saisho Y, Hirakawa Y, Yoshida D, Hata J, Mukai N, . Association of glucose tolerance status with pancreatic β- and α-cell mass in community-based autopsy samples of Japanese individuals: the Hisayama Study. J Diabetes Investig. 2020;11(5):1197–206. Sasaki T, Izumaru K, Hata J, Sakata S, Oishi E, Nagata T, . Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: the Hisayama Study. J Cardiol. 2021;78(3):237–43. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, . Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961–2009). Circulation. 2013;128(11):1198–205. Nakano T, Ninomiya T, Sumiyoshi S, Onimaru M, Fujii H, Itabe H, . Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study. Kidney Int. 2013;84(2):373–80. Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, . An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2013 Jan;36(1):43–9. Kernohan JW, Anderson EW, Keith NM. The arterioles in cases of hypertension. Arch Intern Med. 1929;44(3):395–423. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, . Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem. 1999;274(8):4985–94. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508–16. Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, . Reduced estimated GFR and cardiac remodeling: a population-based autopsy study. Am J Kidney Dis. 2019;74(3):373–81. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, . Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol. 2007 Jul;18(7):2135–42. Takae K, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, . Serum uric acid as a risk factor for chronic kidney disease in a Japanese community: the Hisayama Study. Circ J. 2016;80(8):1857–62. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, . Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282(6):F991–7. Ninomiya T. Japanese legacy cohort studies: the Hisayama Study. J Epidemiol. 2018;28(11):444–51. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–62. Sánchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, . Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008;295(4):1134–41. Kanda E, Muneyuki T, Kanno Y, Suwa K, Nakajima K. Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One. 2015;10(2):e0118031. Kumar V, Abbas AK, Aster JC. Robbins basic pathology. 10th ed.Philadelphia: Elsevier; 2018. Burchfiel CM, Tracy RE, Chyou PH, Strong JP. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):760–8. Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, . Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295(5):1183–90. Sánchez-Lozada LG, Tapia E, López-Molina R, Nepomuceno T, Soto V, Ávila-Casado C, . Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol. 2007;292(4):1238–44. Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, . Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol. 2015;41(2):138–46. Mori K, Furuhashi M, Tanaka M, Numata K, Hisasue T, Hanawa N, . U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2. Hypertens Res. 2021;44(1):107–16. Bader H, Meyer DS. The size of the juxtaglomerular apparatus in diabetic glomerulosclerosis and its correlation with arteriolosclerosis and arterial hypertension: a morphometric light microscopic study on human renal biopsies. Clin Nephrol. 1977;8(1):308–11. |
References_xml | |
SSID | ssj0012807 |
Score | 2.3835654 |
Snippet | Introduction: Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined... Information regarding the influence of serum uric acid (SUA) levels on pathological changes in the kidney is limited. In this study, we examined the... |
SourceID | pubmed karger |
SourceType | Index Database Enrichment Source Publisher |
StartPage | 69 |
SubjectTerms | Arteriosclerosis - diagnosis Arteriosclerosis - epidemiology Autopsy Humans Nephrosclerosis Patient-Oriented, Translational Research: Research Article Risk Factors Sclerosis Uric Acid |
Title | Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study |
URI | https://karger.com/doi/10.1159/000521426 https://www.ncbi.nlm.nih.gov/pubmed/35104828 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PS8MwFA46Zewi_pg6nZKD14Jt07TxVsUxhi07ONhtpH0JFFk3bHfYf-9LUwsOvOSQkBbee8n3krz3PUKeRK69Jko8Ezx3mBdKJxLmAl6BLzJEXBmYbOQk5dMFmy2DZXvfYXJhvkz8c0ON2nELIOA2pecMORg_JideyJk5ZiWO070XeG1iNAI67rkiaDmE_kwdkL6PFsgiU3n91P7owJlsQGVyTs5ab5DGVn0X5EiVl6SftO_dVyTDpbxb0wVuVjTOC6AfJsanonj8p6lCPWwqnIdtUdGipJLOu3pcziviE9B4V2-21Z6aeMH9C0WroNOiknu5lrZvSBaT98-3qdNWRXDyIIpqh4MWTAdgqOE1OgiBCxB4MkTPCBiAYdASrgDfRVcr9JnkoFgoWeBpJXI3Av-a9MpNqW4Jzf0s588ZSEMaF0ZaAue5DF0NmVJZBCMytGJabS31xcpKckTGB_3xLLVDqy3oEbmxQu2Gf-V-988H78nAMwbTREOPSa_-3qkHBPs6e2z0jG06T34A6DOioQ |
link.rule.ids | 315,783,787,27647,27936,27937 |
linkProvider | Karger AG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Uric+Acid+Levels+and+Nephrosclerosis+in+a+Population-Based+Autopsy+Study%3A+The+Hisayama+Study&rft.jtitle=American+journal+of+nephrology&rft.au=Maki%2C+Kenji&rft.au=Hata%2C+Jun&rft.au=Sakata%2C+Satoko&rft.au=Oishi%2C+Emi&rft.date=2022-02-01&rft.issn=0250-8095&rft.eissn=1421-9670&rft.volume=53&rft.issue=1&rft.spage=69&rft.epage=77&rft_id=info:doi/10.1159%2F000521426&rft_id=info%3Apmid%2F35104828&rft.externalDocID=521426 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-8095&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-8095&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-8095&client=summon |